Congestive Heart Failure News and Research RSS Feed - Congestive Heart Failure News and Research

Congestive Heart Failure is a condition in which the heart can't pump blood the way it should. In some cases, the heart can't fill with enough blood. In other cases, the heart can't send blood to the rest of the body with enough force. Some people have both problems. "Heart failure" doesn't mean that your heart has stopped or is about to stop working. However, it's a serious condition that requires medical care. Heart failure develops over time as the pumping of the heart grows weaker. It can affect the right side of the heart only or both the left and right sides of the heart. Most cases involve both sides of the heart.

iGetBetter joins Massachusetts Hospital Association to reduce hospital readmissions

iGetBetter, a supplier of post-acute care transition solutions designed to help reduce hospital readmissions, and the Massachusetts Hospital Association (MHA), the primary representative of the hospital community in the commonwealth, announced today that iGetBetter will join MHA and contribute to efforts now underway by Massachusetts hospitals to improve post-discharge care transition and reduce hospital readmissions. [More]
TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $2.1 million from the National Institutes of Health to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and congestive heart failure. [More]

TSRI reveals new aspects of more potent anti-diabetic drugs with fewer serious side effects

Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. [More]

Findings could lead to more potent anti-diabetic drugs with fewer side effects

Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects. [More]
Ablative Solutions’ Peregrine System Infusion Catheter receives FDA clearance

Ablative Solutions’ Peregrine System Infusion Catheter receives FDA clearance

Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter. [More]

Ablative Solutions' Peregrine System Infusion Catheter receives FDA clearance

Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Peregrine System™ Infusion Catheter. [More]

Rite Aid announces acquisition of Health Dialog Services

Rite Aid Corporation announced today it has acquired Boston-based Health Dialog Services Corporation, a leading provider of health coaching, shared decision making and healthcare analytics from Bupa, a London-based international healthcare services group. Through the acquisition, Health Dialog will operate as a wholly owned subsidiary of Rite Aid. Details of the transaction were not disclosed. [More]
Women who drink too many diet drinks a day more likely to have heart problems

Women who drink too many diet drinks a day more likely to have heart problems

It appears healthy postmenopausal women who drink two or more diet drinks a day may be more likely to have a heart attack, stroke or other cardiovascular problems, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]
Cardiovascular disease related deaths drop after implementation of public smoking ban

Cardiovascular disease related deaths drop after implementation of public smoking ban

A new study on the impact of Michigan's statewide smoking ban adds to mounting evidence that policies prohibiting tobacco smoking in workplaces and other public spaces may substantially improve public health by reducing heart disease and death, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]

ZS Pharma starts patient enrollment in ZS-9 Phase 3 trial for treatment of hyperkalemia

ZS Pharma, a specialty pharmaceutical company developing novel treatments for kidney, cardiovascular and liver disorders, today announced that it has begun enrolling patients in ZS004, its second Phase 3 clinical trial of ZS-9, a novel investigational treatment for hyperkalemia. [More]

Improving coordination of care for elderly patients trims costs and complications

Improving the coordination of care for elderly patients with chronic diseases trims costs, reduces use of health services and cuts complications, according to a new RAND Corporation study. [More]
Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Pierre Fabre Dermatologie has obtained marketing authorization from the FDA for the pediatric drug Hemangeol (propranolol hydrochloride), which is the first and only approved treatment for "proliferating infantile hemangioma requiring systemic therapy". [More]
Stem cell therapy may benefit patients with debilitating heart failure

Stem cell therapy may benefit patients with debilitating heart failure

Researchers want to know whether patients with debilitating heart failure can benefit by having their own stem cells injected into their ailing heart muscle. [More]
Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival. [More]
Bosch Healthcare selects Brain Resource's MyBrainSolutions for use in telehealth solution

Bosch Healthcare selects Brain Resource's MyBrainSolutions for use in telehealth solution

Brain Resource has announced today that Robert Bosch Healthcare Systems, Inc. (headquarters in Palo Alto, California, USA), the market leader in evidence-based telehealth solutions, has added MyBrainSolutions to their newly launched Health Buddy Web solution for the monitoring, education, and management of people living with chronic conditions. [More]
Researchers look at health threat to pregnant women with history of Kawasaki disease

Researchers look at health threat to pregnant women with history of Kawasaki disease

In the first study of its type, researchers at the University of California, San Diego School of Medicine have looked at the health threat to pregnant women with a history of Kawasaki disease (KD), concluding that the risks are low with informed management and care. [More]

Study finds significant reduction in hospital admissions with Medicare Part D prescription coverage

A new study by the Johns Hopkins Bloomberg School of Public Health and the University of Illinois at Chicago finds that Medicare Part D prescription coverage significantly reduced hospital admissions and program expenditures totaling $1.5 billion annually. [More]

NCKU research team identifies medicine capable of rejuvenating aged hearts

A southern Taiwan-based National Cheng Kung University (NCKU) research team has identified the critical time period and a drug as treatment for cardiac repairing, the university revealed recently at a press conference. [More]
Study to examine effectiveness of using video calls to deliver care for people with Parkinson's disease

Study to examine effectiveness of using video calls to deliver care for people with Parkinson's disease

People living with Parkinson's disease today often face challenges when seeking care, including disability, distance from medical centers, and distribution of doctors. In fact, 42 percent of those diagnosed with Parkinson's disease, and more living with the condition, do not see a neurologist for their care. Now, a national study will attempt to disrupt the status quo and bring expert Parkinson's care directly into patients' homes using video visit technology. [More]
Bosch Healthcare receives NCQA's Disease Management certification for HMPs

Bosch Healthcare receives NCQA's Disease Management certification for HMPs

Robert Bosch Healthcare Systems, Inc., the market leader in evidence-based telehealth solutions, today announced the that it has received certification for program design in Disease Management for 16 Health Management Programs (HMPs) that it submitted to the National Committee for Quality Assurance. [More]